Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 18, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

July 31, 2026

Conditions
NarcolepsyIdiopathic Hypersomnia
Interventions
DIAGNOSTIC_TEST

24-hour Ambulatory Blood Pressure Monitoring

Arm blood pressure cuff that will automatically inflate every 15-30 minutes to check blood pressure while awake and asleep over 24 hours. Patient will also complete a sleep diary and wear an actigraphy watch during this test.

DIAGNOSTIC_TEST

Oculo-Cognitive Addition Test (OCAT)

Tracks users' eye movements as they complete a simple mental addition test.

Trial Locations (1)

85259

Mayo Clinic Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05371483 - Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments | Biotech Hunter | Biotech Hunter